PPIST00491
Protein Information
| Protein_Chain | B[auth H] |
|---|---|
| Protein_Sequence | IVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTVDDLLVRIGKHSRTRYERKVEKISMLDKIYIHPRYNWKENLDRDIALLKLKRPIELSDYIHPVCLPDKQTAAKLLHAGFKGRVTGWGNRRETWTTSVAEVQPSVLQVVNLPLVERPVCKASTRIRITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSPYNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDRLGS |
Peptide Information
| Peptide_Chain | A[auth L] |
|---|---|
| Peptide_Sequence | TSEDHFQPFFNEKTFGAGEADCGLRPLFEKKQVQDQTEKELFESYIEGR |
| Peptide_Length | 49 |
| Non-standard residues | No |
Interaction Information
| PDB_ID | 1UVU |
|---|---|
| Method | X-RAY DIFFRACTION |
| Resolution | 2.80 angstrom |
| Structure | |
| Protein-peptide residue interaction | |
| Interaction_xlsx | Download interaction table (.xlsx) |
Reference Information
| Title | Enzyme flexibility, solvent and 'weak' interactions characterize thrombin-ligand interactions: implications for drug design. |
|---|---|
| Release_Year | 1996 |
| PMID | 8939759 |
| DOI | 10.1016/S0969-2126(96)00142-6 |